EMAIL THIS PAGE TO A FRIEND

Journal of tissue engineering and regenerative medicine

A rapid method for obtaining mesenchymal stem cells and platelets from bone marrow aspirate.


PMID 22715158

Abstract

Mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) are currently used alone or in combination for therapeutic applications especially for bone repair. We tested whether MSCs can be isolated from bone marrow (BM) aspirate using a commercially available kit commonly used to obtain PRP from peripheral blood (PB). Results revealed that mononuclear cells and platelets from both PB and BM could be efficiently isolated by obtaining a mononuclear and platelet rich fraction (PB-MPRF and BM-MPRF, respectively). Starting with comparable volumes, the number of platelets increased 1.5-fold in BM-MPRF compared to PB-MPRF. The number of clonogenic cells in BM-MPRF samples was significantly higher than whole BM samples as revealed by CFU-F assay (54.92 ± 8.55 CFU-F/1.5 x 10(5) nucleated cells and 32.50 ± 12.43 CFU-F/1.5 x 10(5) nucleated cells, respectively). Cells isolated from BM-MPRF after in vitro expansion fulfilled the definition of MSCs by phenotypic criteria, and differentiated along osteogenic, adipogenic and chondrogenic lineages following induction. Results showed that the kit isolated MSCs and platelets from BM aspirate. Isolated MSCs were further expanded in a laboratory and BM-MPRF was used clinically following BM withdrawal for rapid intra-operative cell therapy for the treatment of bone defects.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

GW10811F Anti-CD34 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB4300690
Anti-CD34 antibody produced in rabbit, affinity isolated antibody
C1000000
Cetylpyridinium chloride, European Pharmacopoeia (EP) Reference Standard
C21H38ClN · H2O
C0732
Cetylpyridinium chloride, meets USP testing specifications
C21H38ClN · H2O
1104006
Cetylpyridinium chloride, United States Pharmacopeia (USP) Reference Standard
C21H38ClN · H2O
1341001
Indomethacin, United States Pharmacopeia (USP) Reference Standard
C19H16ClNO4
I0200000
Indomethacin, European Pharmacopoeia (EP) Reference Standard
C19H16ClNO4
PHR1247
Indomethacin, Pharmaceutical Secondary Standard; Certified Reference Material
C19H16ClNO4
SAB4700100
Monoclonal Anti-CD14-FITC antibody produced in mouse, clone MEM-15, purified immunoglobulin, buffered aqueous solution
SAB4700106
Monoclonal Anti-CD14-FITC antibody produced in mouse, clone MEM-18, purified immunoglobulin, buffered aqueous solution
WH0000947M1
Monoclonal Anti-CD34 antibody produced in mouse, clone 5F3, purified immunoglobulin, buffered aqueous solution
SAB1403649
Monoclonal Anti-CD34 antibody produced in mouse, clone 5A6, purified immunoglobulin, buffered aqueous solution
SAB4700160 Monoclonal Anti-CD34 antibody produced in mouse, clone 4H11[APG], purified immunoglobulin, buffered aqueous solution
SAB4700736 Monoclonal Anti-CD34 antibody produced in mouse, clone 581, purified immunoglobulin, buffered aqueous solution